Daily Digit: Novartis raises outlook (0:59)
Oct. 22 - Swiss drug maker Novartis raises its full-year outlook for a second consecutive quarter, due to the ongoing absence of generic competition to its best-selling blood pressure pill, Diovan. Hayley Platt reports. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.